compound semaglutide stopping versions of GLP-1 drugs for weight loss halted by FDA HappyDays2025 Subscription:3 months Andrew Hardaway, Ph.D., explains

compound semaglutide stopping versions of GLP-1 drugs for weight loss halted by FDA HappyDays2025 Subscription:3 months Andrew Hardaway, Ph.D., explains

Andrew Hardaway, Ph.D., explains his research on GLP-1 weight loss drugs and how hormones influence brain circuits that regulate appetite and reward. Learn more at the link in our bio!

“The FTC alleged they sold weight-loss programs with undisclosed costs and membership commitments, making unsubstantiated claims about the weight loss achieved by their clients, using fake testimonials, and unfairly distorting consumer reviews,” a FTC statement said

HappyDays2025

Subscription:3 months

3 The full list: A few things worth noticing